查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1756412

疼痛管理治療市場，按疼痛類型、藥物類別、給藥途徑、最終用戶、國家和地區分類 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Pain Management Therapeutics Market, By Type of Pain, By Drug Class, By Administration Route, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年疼痛管理治療市場規模價值為 849.78 億美元，2025 年至 2032 年的複合年成長率為 3.78%。

推動這一市場發展的因素包括慢性病盛行率上升、人口老化以及人們對疼痛管理方案的認知不斷提高。藥物配方和給藥方式的創新也擴大了治療的可能性。此外，對非成癮性、更安全的止痛替代品的需求日益成長，也正在塑造市場趨勢。此領域涵蓋與癌症、關節炎、神經病變和術後恢復相關的疼痛。總而言之，它透過解決全球最常見且最具挑戰性的疼痛症狀之一，在醫療保健領域發揮著至關重要的作用。

疼痛管理治療市場-市場動態

對非鴉片類止痛藥的需求不斷成長，推動了更安全的治療替代方案的出現。

非鴉片類止痛藥需求的不斷成長是疼痛管理治療市場的重要驅動力。對鴉片類藥物成癮、濫用和副作用的擔憂促使患者和醫療保健提供者尋求更安全的替代方案。非鴉片類藥物療法，包括非類固醇抗發炎藥、抗驚厥藥、抗憂鬱藥和局部治療，能有效緩解疼痛，且風險較低。

這一轉變得益於全球範圍內日益增多的認知宣傳活動以及對鴉片類藥物處方更嚴格的監管。此外，研究的進步也催生了能夠更精準地靶向疼痛機制的創新非鴉片類藥物。因此，市場正在擴大其產品組合，以納入這些更安全的選擇。這一趨勢在慢性疼痛治療​​中尤其重要，因為長期使用鴉片類藥物往往會帶來問題。總體而言，對非鴉片類藥物的需求正在重塑治療方法，並加速市場成長。

疼痛管理治療市場—關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 3.78%。

根據疼痛類型細分，慢性疼痛預計在 2024 年佔據最大市場佔有率

根據藥物類別細分，鴉片類藥物是 2024 年領先的藥物類別

根據給藥途徑細分，口服是 2024 年領先的通路

根據最終用戶細分，醫院是 2024 年的主要分銷管道

按地區分類，北美是 2024 年的主要收入來源

疼痛管理治療市場-細分分析：

全球疼痛管理治療市場根據疼痛類型、藥物類別、分佈、最終用戶和地區進行細分。

依疼痛類型，市場分為五類：急性疼痛、慢性疼痛、癌症疼痛、神經性疼痛、術後疼痛。慢性疼痛由於其普遍性和長期性，在疼痛管理治療市場中佔據主導地位。與暫時性且與損傷或手術有關的急性疼痛不同，慢性疼痛會持續數月或數年，通常由關節炎、神經病變或纖維肌痛等疾病引起。慢性疼痛的管理具有挑戰性，因為它會嚴重影響患者的生活品質和日常功能。這導致對有效且永續的疼痛緩解療法的需求日益成長。全球老齡人口和慢性病病例的增加進一步推動了對慢性疼痛的創新療法的需求。

依藥物類別，市場可分為五類：鴉片類藥物、非鴉片類止痛藥、輔助性止痛藥、局部止痛藥、其他。鴉片類藥物因其在緩解中度至重度疼痛方面的強大功效，仍然是疼痛管理治療市場中的主導藥物類別。它們透過與大腦和脊髓中的鴉片受體結合，顯著降低痛覺。儘管鴉片類藥物療效顯著，但由於對成癮性和副作用的擔憂，其使用受到監管加強，並趨於謹慎。然而，鴉片類藥物仍然被廣泛使用，尤其是在癌症疼痛和術後疼痛管理方面。更安全的鴉片類藥物製劑的持續開發旨在平衡疼痛緩解與風險最小化，從而保持其在疼痛治療中的關鍵地位。

疼痛管理治療市場-地理洞察

北美地區憑藉其完善的醫療基礎設施和較高的慢性疼痛盛行率，在疼痛管理治療市場中佔據主導地位。美國引領市場，主要原因是其老化人口中關節炎、癌症和神經性疼痛病例的增加。此外，人們對疼痛管理方案的認知不斷提高，以及先進療法的廣泛應用也促進了市場的成長。該地區的監管機構正在推廣更安全的疼痛管理實踐，這加速了向非鴉片類藥物替代品的轉變。

美國是北美疼痛管理治療市場的最大貢獻者，這得益於慢性疼痛疾病的高發性和人口老化。人們對鴉片類藥物成癮的認知不斷提高，推動了對更安全的非鴉片類止痛藥的需求。強大的醫療基礎設施、先進的研究以及政府對疼痛管理的支持措施進一步增強了市場的成長。領先製藥公司的入駐也促進了疼痛治療領域的持續創新。

疼痛管理治療市場-競爭格局：

疼痛管理治療市場的競爭格局瞬息萬變，領先的製藥和生技公司之間競爭激烈。主要參與者專注於產品創新、策略合作和收購，以鞏固其市場地位。各公司正大力投資研發，以創造更安全、更有效的疼痛緩解方案，尤其是非鴉片類藥物療法，以滿足不斷變化的監管要求和患者偏好。

市場也見證了基於藥物配方、給藥技術和定價策略的競爭。擁有創新治療方案的新興企業正在挑戰老牌企業，推動進一步的創新。此外，各公司正在透過合作和授權協議擴大其地域覆蓋範圍。持續的鴉片類藥物危機促使各公司加速開發替代性疼痛管理療法，加劇了市場競爭。總體而言，這種競爭環境促進了持續的進步，使全球患者和醫療保健提供者受益。

最新動態：

2025年1月，Vertex Pharmaceuticals公司獲得FDA核准，其新藥Journavx（舒澤三嗪）用於治療中度至重度急性疼痛。這是二十多年來首個核准的新型止痛藥。 Journavx標靶作用於痛覺神經元特異的鈉通道，有效緩解疼痛，且不具備鴉片類藥物的成癮性。此次批准標誌著非鴉片類疼痛治療領域取得重大進展。

目錄

第1章：疼痛管理治療市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 疼痛管理治療市場片段（依疼痛類型分類）
    • 疼痛管理治療市場（依藥物類別）
    • 疼痛管理治療市場依給藥途徑分類
    • 疼痛管理治療市場片段（按最終用戶）
    • 疼痛管理治療市場（按國家/地區）
    • 疼痛管理治療市場（按地區）
  • 競爭洞察

第3章：疼痛管理治療的關鍵市場趨勢

  • 疼痛管理治療市場促進因素
    • 市場促進因素的影響分析
  • 疼痛管理治療市場的限制
    • 市場限制的影響分析
  • 疼痛管理治療市場機遇
  • 疼痛管理治療市場未來趨勢

第4章：疼痛管理治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：疼痛管理治療市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：疼痛管理治療市場格局

  • 2024年疼痛管理治療市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：疼痛管理治療市場－按疼痛類型

  • 概述
    • 依疼痛類型分析細分市場佔有率
    • 急性疼痛
    • 慢性疼痛
    • 癌症痛
    • 神經性疼痛
    • 術後疼痛

第 8 章：疼痛管理治療市場 - 按藥物類別

  • 概述
    • 按藥物類別分類的細分市場佔有率分析
    • 鴉片類藥物
    • 非鴉片類鎮痛藥
    • 輔助止痛藥
    • 局部止痛藥
    • 其他

第9章：疼痛管理治療市場－依給藥途徑

  • 概述
    • 按管理途徑分類的細分市場佔有率分析
    • 口服
    • 注射劑
    • 透皮
    • 外用

第 10 章：疼痛管理治療市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 門診手術中心
    • 居家照護環境
    • 其他

第 11 章：疼痛管理治療市場 - 按地域分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美疼痛管理治療主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按疼痛類型）
    • 北美市場規模及預測（依藥品類別）
    • 北美市場規模及預測（依行政路線）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲疼痛管理治療主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按疼痛類型）
    • 歐洲市場規模及預測（依藥品類別）
    • 歐洲市場規模及預測（依行政路線）
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區疼痛管理治療主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區疼痛市場規模及預測（依疼痛類型）
    • 亞太地區市場規模及預測（依藥品類別）
    • 亞太地區市場規模及預測（依行政路線）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲疼痛管理治療主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依疼痛類型分類）
    • 拉丁美洲市場規模及預測（依藥品類別）
    • 拉丁美洲市場規模及預測（依管理途徑）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲疼痛管理治療主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依疼痛類型）
    • MEA 市場規模及預測（依藥物類別）
    • MEA 市場規模及預測（依管理途徑）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：關鍵供應商分析-疼痛管理治療產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Johnson & Johnson
    • Pfizer Inc.
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Eli Lilly and Company
    • Novartis AG
    • Grunenthal GmbH
    • Mylan NV
    • Mallinckrodt Pharmaceuticals
    • Sanofi SA
    • Allergan (AbbVie)
    • AstraZeneca plc
    • Endo International plc
    • Bristol-Myers Squibb
    • Bayer AG
    • AcelRx Pharmaceuticals

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5318

REPORT HIGHLIGHT

Pain Management Therapeutics Market size was valued at US$ 84,978 Million in 2024, expanding at a CAGR of 3.78% from 2025 to 2032.

The Pain Management Therapeutics Market focuses on treatments and medications designed to relieve or reduce pain caused by various medical conditions. This market includes a wide range of products such as opioids, non-opioid analgesics, anti-inflammatory drugs, topical agents, and advanced therapies like nerve blocks and neuromodulation. The primary goal is to improve patient quality of life by managing acute and chronic pain effectively.

Factors driving this market include the rising prevalence of chronic diseases, an aging population, and increasing awareness about pain management options. Innovations in drug formulations and delivery methods are also expanding therapeutic possibilities. Additionally, the growing demand for non-addictive and safer pain relief alternatives is shaping market trends. The sector covers pain related to cancer, arthritis, neuropathic conditions, and postoperative recovery. Overall, it plays a critical role in healthcare by addressing one of the most common and challenging symptoms experienced worldwide.

Pain Management Therapeutics Market- Market Dynamics

Rising demand for non-opioid pain relief fuels safer therapeutic alternatives.

The rising demand for non-opioid pain relief is a significant driver in the Pain Management Therapeutics Market. Concerns over opioid addiction, abuse, and side effects have pushed both patients and healthcare providers to seek safer alternatives. Non-opioid therapies, including NSAIDs, anticonvulsants, antidepressants, and topical treatments, offer effective pain relief with lower risk profiles.

This shift is supported by growing awareness campaigns and stricter regulations on opioid prescriptions worldwide. Additionally, advancements in research are producing innovative non-opioid drugs that target pain mechanisms more precisely. As a result, the market is expanding its portfolio to include these safer options. This trend is especially important in managing chronic pain conditions, where long-term opioid use is often problematic. Overall, the demand for non-opioid therapies is reshaping treatment approaches and accelerating market growth.

Pain Management Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.78% over the forecast period (2025-2032)

Based on Type of Pain segmentation, Chronic Pain was predicted to show maximum market share in the year 2024

Based on Drug Class segmentation, Opioids was the leading Drug Class in 2024

Based on Administration Route segmentation, Oral was the leading distribution in 2024

Based on end-user segmentation, Hospitals was the leading distribution in 2024

On the basis of region, North America was the leading revenue generator in 2024

Pain Management Therapeutics Market- Segmentation Analysis:

The Global Pain Management Therapeutics Market is segmented on the basis of Type of Pain, Drug Class, Distribution, End-user, and Region.

The market is divided into five categories based on Type of Pain: Acute Pain, Chronic Pain, Cancer Pain, Neuropathic Pain, Postoperative Pain. Chronic pain is the dominant segment in the Pain Management Therapeutics Market due to its widespread prevalence and long-lasting nature. Unlike acute pain, which is temporary and linked to injury or surgery, chronic pain persists for months or years, often resulting from conditions like arthritis, neuropathy, or fibromyalgia. Managing chronic pain is challenging because it significantly affects patients' quality of life and daily functioning. This has led to a growing demand for effective and sustainable pain relief therapies. The rising number of aging populations and chronic disease cases worldwide further drive the need for innovative treatments targeting chronic pain.

The market is divided into five categories based on Drug Class: Opioids, Non-Opioid Analgesics, Adjuvant Analgesics, Topical Analgesics, Others. Opioids remain the dominant drug class in the Pain Management Therapeutics Market due to their strong effectiveness in relieving moderate to severe pain. They work by binding to opioid receptors in the brain and spinal cord, significantly reducing pain perception. Despite their high efficacy, concerns over addiction and side effects have led to increased regulation and cautious use. However, opioids continue to be widely prescribed, especially for cancer pain and postoperative pain management. The ongoing development of safer opioid formulations aims to balance pain relief with minimizing risks, maintaining their key role in pain therapeutics.

Pain Management Therapeutics Market- Geographical Insights

The North American region holds a dominant position in the Pain Management Therapeutics Market due to its well-established healthcare infrastructure and high prevalence of chronic pain conditions. The United States leads the market, driven by increasing cases of arthritis, cancer, and neuropathic pain among its aging population. Additionally, growing awareness about pain management options and widespread adoption of advanced therapies contribute to market growth. Regulatory agencies in the region are promoting safer pain management practices, which has accelerated the shift toward non-opioid alternatives.

The United States is the largest contributor to the Pain Management Therapeutics Market within North America, driven by a high prevalence of chronic pain conditions and an aging population. Increased awareness about opioid addiction has boosted demand for safer, non-opioid pain relief options. Robust healthcare infrastructure, advanced research, and government initiatives supporting pain management further strengthen market growth. The presence of leading pharmaceutical companies also fosters continuous innovation in pain therapeutics.

Pain Management Therapeutics Market- Competitive Landscape:

The competitive landscape of the Pain Management Therapeutics Market is highly dynamic and characterized by intense rivalry among leading pharmaceutical and biotech companies. Key players focus on product innovation, strategic partnerships, and acquisitions to strengthen their market positions. Companies are investing heavily in research and development to create safer and more effective pain relief options, particularly non-opioid therapies, to meet changing regulatory requirements and patient preferences.

The market also witnesses competition based on drug formulations, delivery technologies, and pricing strategies. Emerging players with novel therapeutic solutions are challenging established firms, driving further innovation. Additionally, companies are expanding their geographic presence through collaborations and licensing agreements. The ongoing opioid crisis has pushed companies to accelerate development of alternative pain management therapies, increasing market competition. Overall, this competitive environment fosters continuous advancements that benefit patients and healthcare providers worldwide.

Recent Developments:

In January 2025, Vertex Pharmaceuticals received FDA approval for Journavx (suzetrigine), a novel non-opioid painkiller for moderate-to-severe acute pain. This marks the first approval of a new class of pain medication in over two decades. Journavx targets sodium channels specific to pain neurons, offering effective pain relief without the addictive potential of opioids. The approval signifies a significant advancement in non-opioid pain management options.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson
  • Pfizer Inc.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Novartis AG
  • Grunenthal GmbH
  • Mylan N.V.
  • Mallinckrodt Pharmaceuticals
  • Sanofi S.A.
  • Allergan (AbbVie)
  • AstraZeneca plc
  • Endo International plc
  • Bristol-Myers Squibb
  • Bayer AG
  • AcelRx Pharmaceuticals

GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY TYPE OF PAIN- MARKET ANALYSIS, 2019 - 2032

  • Acute Pain
  • Chronic Pain
  • Cancer Pain
  • Neuropathic Pain
  • Postoperative Pain

GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032

  • Opioids
  • Non-Opioid Analgesics
  • Adjuvant Analgesics
  • Topical Analgesics
  • Others

GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY ADMINISTRATION ROUTE- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable
  • Transdermal
  • Topical

GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pain Management Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pain Management Therapeutics Market Snippet by Type of Pain
    • 2.1.2. Pain Management Therapeutics Market Snippet by Drug Class
    • 2.1.3. Pain Management Therapeutics Market Snippet by Administration Route
    • 2.1.4. Pain Management Therapeutics Market Snippet by End-user
    • 2.1.5. Pain Management Therapeutics Market Snippet by Country
    • 2.1.6. Pain Management Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Pain Management Therapeutics Key Market Trends

  • 3.1. Pain Management Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pain Management Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pain Management Therapeutics Market Opportunities
  • 3.4. Pain Management Therapeutics Market Future Trends

4. Pain Management Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pain Management Therapeutics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pain Management Therapeutics Market Landscape

  • 6.1. Pain Management Therapeutics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pain Management Therapeutics Market - By Type of Pain

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type of Pain, 2024 & 2032 (%)
    • 7.1.2. Acute Pain
    • 7.1.3. Chronic Pain
    • 7.1.4. Cancer Pain
    • 7.1.5. Neuropathic Pain
    • 7.1.6. Postoperative Pain

8. Pain Management Therapeutics Market - By Drug Class

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 8.1.2. Opioids
    • 8.1.3. Non-Opioid Analgesics
    • 8.1.4. Adjuvant Analgesics
    • 8.1.5. Topical Analgesics
    • 8.1.6. Others

9. Pain Management Therapeutics Market - By Administration Route

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Administration Route, 2024 & 2032 (%)
    • 9.1.2. Oral
    • 9.1.3. Injectable
    • 9.1.4. Transdermal
    • 9.1.5. Topical

10. Pain Management Therapeutics Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers
    • 10.1.4. Home Care Settings
    • 10.1.5. Others

11. Pain Management Therapeutics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Pain Management Therapeutics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Pain Management Therapeutics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Pain Management Therapeutics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Pain Management Therapeutics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Pain Management Therapeutics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pain Management Therapeutics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Johnson & Johnson
    • 12.2.2. Pfizer Inc.
    • 12.2.3. AbbVie Inc.
    • 12.2.4. Teva Pharmaceutical Industries Ltd.
    • 12.2.5. Eli Lilly and Company
    • 12.2.6. Novartis AG
    • 12.2.7. Grunenthal GmbH
    • 12.2.8. Mylan N.V.
    • 12.2.9. Mallinckrodt Pharmaceuticals
    • 12.2.10. Sanofi S.A.
    • 12.2.11. Allergan (AbbVie)
    • 12.2.12. AstraZeneca plc
    • 12.2.13. Endo International plc
    • 12.2.14. Bristol-Myers Squibb
    • 12.2.15. Bayer AG
    • 12.2.16. AcelRx Pharmaceuticals

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us